image:Collaboration between the Global Alliance for Genomics and Health (GA4GH) and the Standards Council of Canada resulted in GA4GH Phenopackets being published as an ISO standard. view more
Credit: GA4GH / Stephanie Li
The International Organization for Standardization (ISO) has published Phenopackets, the first clear computational way to responsibly share individual patient traits, removing a major barrier to research on disease diagnosis, treatment, and mechanism discovery.
The standard was initially developed by the Global Alliance for Genomics and Health (GA4GH) and championed at ISOunder the Canadian Mirror Committee to ISO/TC215/SC1Genomics informatics, and supported by the Standards Council of Canada.
We finally have the very first standard for phenotype data available worldwide, said University of Colorado professor Melissa Haendel, a GA4GH contributor who launched the Phenopacket idea eight years ago.
Having this ISO standard will encourage software developers, infrastructure developers, healthcare systems to consider Phenopackets as a method for sharing patient-level information securely and in a deidentified way that can be useful for everything from rare to infectious diseases, and addressing many kinds of public health questions, Haendel said.
The standard, ISO 4454 Genomics informatics Phenopackets: A format for phenotypic data exchange, was published on 6 July 2022.
Phenopackets debuted at ISO thanks to theleadership of GA4GH and through the support of Canadas National Member Body, theStandards Council of Canada (SCC), and itsInnovation Initiative.
Beyond furthering the UN Sustainable Development goals for good health and innovation, Phenopackets has the potential to benefit a range of Canadian and global organisations, from Google to the Canadian Institute of Health Research to the Red Cross.
A Phenopacket is a packet of data typically a file that humans and computers can read. It describes a personsphenotype, a term for the way our genes manifest in our bodies, such as hair colour, hormone levels, or a bad reaction to a drug.
For more than a millennium, physicians have used the same technology for recording and sharing phenotypes: the written note.
While handwritten scrawl has morphed into sophisticated electronic health records, fundamentally, little has changed. Clinicians may record two patients identical phenotypes in vastly different ways that are difficult to compare.
For bioinformaticians studying how genes affect our chances of cancer, rare disease, and illness, this freewheeling flexibility is a problem.
If somebody gives you a piece of paper with a bunch of scribbled stuff and says, Do research with that, youre going to go, Well I dont know what that is! You have to read it, understand it, extract all the data, and make sense of it in your head. And that takes time, said Julius Jacobsen, a bioinformatics software developer at Queen Mary University of London who co-leads the GA4GH team working on Phenopackets.
But the Phenopacket provides a sense of how all the bits fit together, like a blank form. All someone has to do is fill in the pre-existing fields, and then they can give you a nice piece of structured information which anyone can understand, said Jacobsen.
So in 2019, GA4GH the worlds standards organisation for genomics approved thePhenopacket standardfor storing phenotypic data in predictable formats that computers everywhere can read.
A few months later, the newly-formed ISO Genomics Informatics subcommittee met in the South Korean city of Daegu. The group chose Phenopackets as one of its very first standards to develop, working in tandem with GA4GH contributors updating the original version of the standard. (Phenopackets v2was adopted forthe ISO standard after being approved in February.)
To officially propose Phenopackets to ISO, GA4GH Work Stream manager Lindsay Smith, who is based at the Ontario Institute for Cancer Research in Toronto, collaborated with the Canadian Mirror Committee to ISO/TC215/SC1, with the support of SCC.
Through programs like its Innovation Initiative, SCC helps innovators to commercialise technologies and facilitates their participation on national and international standardisation committees for the benefit of economic growth and the health and safety of Canadians.
Finding ways to advance health technologies has been an important area of interest for the Innovation Initiative, said Chantal Guay, CEO of SCC. Developing an ISO standard is key to aligning perspectives internationally and promoting shared health information across the world.
Many rounds of reviews from ISO experts in Japan, India, Canada, the U.S., and Korea ensured that Phenopackets would work in diverse healthcare systems.
In Japan, a network of 14 major biobanks has implemented Phenopackets, with 920,000 samples and 250,000 genomic and omics data provided by 490,000 individuals,said Soichi Ogishima, a member of the ISO project team that reviewed Phenopackets.
Researchers can access phenotypic information with GA4GHs Phenopackets standard for capturing clinical data and integrating them with genomic data to develop precision medicine,added Ogishima, a professor of genomic informatics at Tohoku University in Sendai, Japan.
The humble Phenopacket has the potential to transform the treatment of common disease.
Asthma, inflammatory bowel disease, schizophrenia, and other complex conditions are unlikely to be one disease. But its been difficult to divide these diseases into groups that respond to specific treatments. One reason is because everybody uses their own formats, so you cannot combine data, said Peter Robinson, a computational biologist at the Jackson Laboratory who co-leads the GA4GH Phenopackets development team.
By using Phenopackets, well be able to improve precision medicine for individuals by being able to compare and cluster patients based upon their individual characteristics, he said.
The standard could also improvestudy and diagnosis of rare disease.
There should be a tool for patients to share their information as Phenopackets, said Haendel. Right now, there are rare disease patients all over social media sharing free text that could be structured in such a way that we could mine it as data for example, to identify patients who have the same condition around the world.
Patient matchmaking would get easier with a database of cases described in the Phenopacket format.
Many journals in human genetics are willing to consider cajoling or requiring authors to submit Phenopackets together with case reports. Usually if you find a new disease gene, youll describe ten patients, but none of that information is accessible at the patient level, said Robinson.
In June, Robinson, Jacobsen, Haendel, Smith, and collaborators published anarticle inNature Biotechnologyoutlining how Phenopackets lets researchers and cliniciansexchange patient characteristics more effectively and link those data to genomic information.
While the Phenopacket schema is stillavailable free of costfrom GA4GH, ISO publication significantly broadens its reach. Beyond Japanese biobanks, databases like the widely-used BioSamples have already implemented Phenopackets. Electronic health record vendors and national health systems are considering the standard.
As an added benefit, any organisation that adopts Phenopackets can easily link to other powerful clinical and research tools from the GA4GHGenomic Data Toolkit.
Going forward, there are plans to build Phenopackets into standards for sharing electronic health records, such as Fast Healthcare Interoperability Resources (FHIR) by the Health Level 7 (HL7) organisation.
Phenopackets was chosen as one of HL7sVulcan Accelerator projects. Accelerator projects try to improve how clinical studies are designed, conducted and reported by advancing the implementation of research-ready standards. A project to represent Phenopackets in the FHIR standard is underway to make sure that this schema thats now an ISO standard can also be used in the context of HL7, said Haendel.
Phenopackets may be the first GA4GH standard published by ISO, but it will not be the last. Currently, the ISO Genomics Informatics subcommittee is reviewing a proposed standard for genomic surveillance systems such as the public health systems that track Covid-19 variants spreading around the world. GA4GH standards feature prominently within the requirements.
When standards development organisations align their work, everyone benefits.
The ISO publication of Phenopackets exemplifies the benefits of standards coordination. When different standards-setting bodies collaborate, it amplifies the impact of all our standards. Truly global standards expand responsible data sharing and bring the benefits of precision medicine to more patients and their families, said Peter Goodhand, Chief Executive Officer of GA4GH.
#
About the Global Alliance for Genomics and Health (GA4GH)
The Global Alliance for Genomics and Health (GA4GH) is an international, nonprofit alliance formed in 2013 to accelerate the potential of research and medicine to advance human health. Bringing together 600+ leading organisations working in healthcare, research, patient advocacy, life science, and information technology, the GA4GH community is working together to create frameworks and standards to enable the responsible, voluntary, and secure sharing of genomic and health-related data.
About the Standards Council of Canada (SCC)
Since 1970, the Standards Council of Canada (SCC) has helped make life safer, healthier, more prosperous and sustainable for people, communities and businesses in Canada through the power of standardization. SCC works with a vast network of partners nationally and around the world, acting as Canadas voice on standards and accreditation on the international stage, including as a member of the International Organization for Standardization (ISO) and International Electrotechnical Commission (IEC). As the countrys leading accreditation organization, SCC creates market confidence at home and abroad by ensuring conformity assessment bodies meet the highest expectations. In all these ways, SCC opens a world of possibilities. For more information, visithttps://www.scc-ccn.ca(link is external)
Read the rest here:
Reshaping how doctors and researchers share phenotypic information: first GA4GH standard published by ISO - EurekAlert
- BENITEC BIOPHARMA INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q) - Marketscreener.com - February 13th, 2023 [February 13th, 2023]
- CENTOGENE to Participate in Upcoming Conferences in February in the Lead Up to Rare Disease Day - Marketscreener.com - February 7th, 2023 [February 7th, 2023]
- Gene | Definition, Structure, Expression, & Facts | Britannica - January 27th, 2023 [January 27th, 2023]
- New gene therapy delivers treatment directly to brain - January 27th, 2023 [January 27th, 2023]
- Indian Pharma Congress: Gene-cell therapy, preventive medicine future of health care, says expert - Economic Times - January 25th, 2023 [January 25th, 2023]
- A blood test that identifies people at higher risk of miscarriage? Thats the goal of this award-winning Rutgers med student. - The Philadelphia... - January 19th, 2023 [January 19th, 2023]
- Gene Therapy: Genes As Medicine | Pfizer - January 6th, 2023 [January 6th, 2023]
- How Genomics will ensure a risk-free and beneficial treatment for good health and well-being - The Financial Express - December 28th, 2022 [December 28th, 2022]
- Regenerative Medicine Advanced Therapy Designation | FDA - December 18th, 2022 [December 18th, 2022]
- 3576 - Gene ResultCXCL8 C-X-C motif chemokine ligand 8 [ (human)] - November 23rd, 2022 [November 23rd, 2022]
- Study identifies new gene that drives colon cancer - EurekAlert - October 17th, 2022 [October 17th, 2022]
- Updated Stroke Gene Panels: Rapid evolution of knowledge on monogenic causes of stroke | European Journal of Human Genetics - Nature.com - October 17th, 2022 [October 17th, 2022]
- The challenges of translating CRISPR to the clinic - Labiotech.eu - October 17th, 2022 [October 17th, 2022]
- Editas Medicine Presents Preclinical Data on EDIT-103 for Rhodopsin-associated Autosomal Dominant Retinitis Pigmentosa at the European Society of Gene... - October 17th, 2022 [October 17th, 2022]
- 'We have to find a way': FDA seeks solutions to aid bespoke gene therapy - BioPharma Dive - October 17th, 2022 [October 17th, 2022]
- Mathematical model could bring us closer to effective stem cell therapies - Michigan Medicine - October 17th, 2022 [October 17th, 2022]
- Approval, Commercialization Highlighted at Cell & Gene Meeting on the Mesa - Genetic Engineering & Biotechnology News - October 17th, 2022 [October 17th, 2022]
- CANbridge-UMass Chan Medical School Gene Therapy Research in Oral Presentation at the European Society of Gene and Cell Therapy (ESGCT) 29th Annual... - October 17th, 2022 [October 17th, 2022]
- Depression Treatment: How Genetic Testing Can Help Find the Right Medication - Dunya News - October 17th, 2022 [October 17th, 2022]
- The Risk-Reward Proposition for CGT Clinical Trials - Applied Clinical Trials Online - October 17th, 2022 [October 17th, 2022]
- Precision Medicine Could Get Even More Precise With Allarity Therapeutics Next-Generation Diagnostics - Benzinga - October 17th, 2022 [October 17th, 2022]
- Decibel Therapeutics Receives FDA Clearance of IND Application for DB-OTO, a Gene Therapy Product Candidate Designed to Provide Hearing to Individuals... - October 17th, 2022 [October 17th, 2022]
- Time for your medicine: unlocking the power of our body clocks - The Guardian - October 17th, 2022 [October 17th, 2022]
- Replay establishes distinguished Scientific Advisory Board of genomic medicine and cell therapy experts - Yahoo Finance - October 17th, 2022 [October 17th, 2022]
- Scientists Reappraise the Role of Zombie Cells That Anti-aging Medicine Has Sought to Eliminate - Neuroscience News - October 17th, 2022 [October 17th, 2022]
- Forge Biologics Announces Updated Positive Clinical Data in RESKUE, a Novel Phase 1/2 Gene Therapy Trial for Patients with Krabbe Disease - Business... - October 17th, 2022 [October 17th, 2022]
- Gene Expression Signatures Are Analyzed for Biomarkers of Response in HCC - Targeted Oncology - October 17th, 2022 [October 17th, 2022]
- NHS England World-first national genetic testing service to deliver rapid life-saving checks for babies and kids - NHS England - October 17th, 2022 [October 17th, 2022]
- The proteinprotein relationship that could mend a broken heart - RegMedNet - October 17th, 2022 [October 17th, 2022]
- Study finds microprotein correlated to Alzheimers risk - Daily Trojan Online - October 11th, 2022 [October 11th, 2022]
- Passage Bio Announces Appointment of William Chou, M.D. as Chief Executive Officer - Yahoo Finance - October 11th, 2022 [October 11th, 2022]
- Gene Therapy Rapidly Improves Night Vision in Adults with Congenital Blindness - Newswise - October 11th, 2022 [October 11th, 2022]
- Scientists Discover Protein Partners that Could Heal Heart Muscle | Newsroom - UNC Health and UNC School of Medicine - October 11th, 2022 [October 11th, 2022]
- The Pros and Cons of Lentiviral and Adeno-Associated Viral Vectors - The Medicine Maker - October 11th, 2022 [October 11th, 2022]
- Insights & Outcomes: Foreign DNA, quantum potholes and relapsing fever - Yale News - October 11th, 2022 [October 11th, 2022]
- Expediting IND applications with drug master files - BioPharma Dive - October 11th, 2022 [October 11th, 2022]
- UNC School of Medicine Awarded $3 Million to Lead Study to Reduce PTSD Frequency, Severity | Newsroom - UNC Health and UNC School of Medicine - October 11th, 2022 [October 11th, 2022]
- Lineage to Present at Alliance for Regenerative Medicine 2022 Cell & Gene Meeting on the Mesa - businesswire.com - October 8th, 2022 [October 8th, 2022]
- The Next Crispr Gene Editing IPO Could Be Near - Henry Herald - October 8th, 2022 [October 8th, 2022]
- 10-year CRISPR anniversary: How gene editing revolutionized medicine, and what lies ahead - Genetic Literacy Project - October 8th, 2022 [October 8th, 2022]
- Blood from a baby at birth can be gene sequenced to prevent diseases - USA TODAY - October 8th, 2022 [October 8th, 2022]
- What doctors wish patients knew about breast-cancer prevention - American Medical Association - October 8th, 2022 [October 8th, 2022]
- Growth in Cell and Gene Therapy Market - Pharmaceutical Technology Magazine - October 8th, 2022 [October 8th, 2022]
- Gene Editing Service Market 2022 : Top Players to Reflect Impressive Growth Rate till 2029: Caribou Biosciences, CRISPR Therapeutics, Merck KGaA,... - October 8th, 2022 [October 8th, 2022]
- Tip Sheet: $78 million to support new precision oncology institute, update on experimental gene therapy for herpes and the launch of Fred Hutch's new... - October 8th, 2022 [October 8th, 2022]
- Cell and Gene Therapy: Rewriting the Future of Medicine - Technology Networks - October 2nd, 2022 [October 2nd, 2022]
- Growth in Cell and Gene Therapy Market - BioPharm International - October 2nd, 2022 [October 2nd, 2022]
- CRISPR Therapeutics Announces FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Granted to CTX130 for the Treatment of Cutaneous T-Cell... - October 2nd, 2022 [October 2nd, 2022]
- BioMarin Resubmits Biologics License Application (BLA) for Valoctocogene Roxaparvovec AAV Gene Therapy for Severe Hemophilia A to the FDA - PR... - October 2nd, 2022 [October 2nd, 2022]
- Fighting Breast and Ovarian Cancer With a Lupus Antibody - Yale School of Medicine - October 2nd, 2022 [October 2nd, 2022]
- This gene therapy company is testing new tech to 'switch off' diabetes and obesity with a pill - Euronews - October 2nd, 2022 [October 2nd, 2022]
- Tenaya Therapeutics to Participate in Inaugural Hypertrophic Cardiomyopathy Medical Societys 2022 Scientific Sessions - Yahoo Finance - October 2nd, 2022 [October 2nd, 2022]
- Risk of Alzheimer's dementia may be predicted with help of new tool Washington University School of Medicine in St. Louis - Washington University... - October 2nd, 2022 [October 2nd, 2022]
- Tiny Sea Creature's Genes Shed Light on Evolution of Immunity - UPMC - October 2nd, 2022 [October 2nd, 2022]
- Who will get the call from Stockholm? It's time for STAT's 2022 Nobel Prize predictions - STAT - October 2nd, 2022 [October 2nd, 2022]
- Excision BioTherapeutics Awarded California Institute for Regenerative Medicine (CIRM) Grant to Support Ongoing Phase 1/2 Trial Evaluating EBT-101 as... - October 2nd, 2022 [October 2nd, 2022]
- NeuroVoices: Emma Ciafaloni, MD, on the Vast Expansion of Innovative Approaches to Duchenne Muscular Dystrophy - Neurology Live - October 2nd, 2022 [October 2nd, 2022]
- COVID mRNA Jabs and Testing Kicked Off This Industry of Drug Development: Here's What You Need to Know - The Epoch Times - October 2nd, 2022 [October 2nd, 2022]
- Kidney resident macrophages have distinct subpopulations and occupy distinct microenvironments - University of Alabama at Birmingham - October 2nd, 2022 [October 2nd, 2022]
- Nobel Prize for medicine: the full list of winners - The National - October 2nd, 2022 [October 2nd, 2022]
- The surprising link between circadian disruption and cancer may have to do with temperature - EurekAlert - October 2nd, 2022 [October 2nd, 2022]
- The global live cell imaging market is expected to grow at a CAGR of 8.44% during 2022-2027 - Yahoo Finance - October 2nd, 2022 [October 2nd, 2022]
- Chroma Medicine Announces Formation of Scientific Advisory Board of Global Experts in Gene Editing and Cell and Gene Therapy - PR Newswire - September 20th, 2022 [September 20th, 2022]
- Ring Therapeutics Announces Issuance of U.S. Patent for its Anellovector Compositions - Yahoo Finance - September 20th, 2022 [September 20th, 2022]
- Cholesterol gene mutation: Why would a healthy 27-year-old have severe heart problems? - 69News WFMZ-TV - September 20th, 2022 [September 20th, 2022]
- Gene Therapy for Severe Hemophilia B Could Be More Cost Effective Than Current Treatments - Managed Healthcare Executive - September 20th, 2022 [September 20th, 2022]
- AVROBIO Receives Rare Pediatric Disease Designation from U.S. Food and Drug Administration (FDA) for First Gene Therapy in Development for Cystinosis... - September 20th, 2022 [September 20th, 2022]
- The Biggest CGT Breakthroughs Through the Eyes of Our 2022 Power List - The Medicine Maker - September 20th, 2022 [September 20th, 2022]
- Leading Virus Researcher to Chair UVA's Department of Microbiology, Immunology and Cancer Biology - UVA Health Newsroom - September 20th, 2022 [September 20th, 2022]
- Work remains on Tay-Sachs and other Ashkenazi genetic disorders J. - The Jewish News of Northern California - September 20th, 2022 [September 20th, 2022]
- Study Shows Genetic Link to Moving to the Beat of Music - Newswise - September 20th, 2022 [September 20th, 2022]
- Viewpoint: In the post Roe v Wade world, what changes should a biology textbook writer make to address the medical repercussions of Dobbs? - Genetic... - September 20th, 2022 [September 20th, 2022]
- Alnylam Receives Approval in Europe for AMVUTTRA (vutrisiran) for the Treatment of Hereditary Transthyretin-mediated (hATTR) Amyloidosis in Adult... - September 20th, 2022 [September 20th, 2022]
- CSL flexes gene therapy muscle with latest drug - Sydney Morning Herald - September 20th, 2022 [September 20th, 2022]
- The MIT Press releases new book on the science of the heart from cardiac expert Dr. Sian Harding - EurekAlert - September 20th, 2022 [September 20th, 2022]
- Global Pharmaceutical Contract Manufacturing Market is projected to reach a market value of US$329.7 Billion in 2032: Visiongain Reports Ltd - Yahoo... - September 20th, 2022 [September 20th, 2022]
- Alzheon Reports Industry-Leading Biomarker, Brain Preservation and Clinical Effects Following 12 Months of Treatment in Phase 2 Trial of Oral ALZ-801... - September 20th, 2022 [September 20th, 2022]
- Do You Have Lung Cancer With An EGFR Mutation? If So, The Drug Tagrisso Might Be Right For You Based On New Results From A 'Practice Changing' Trial -... - September 20th, 2022 [September 20th, 2022]
- Getting rid of unwanted transformed cells: Possible new directions in cancer therapy - EurekAlert - September 20th, 2022 [September 20th, 2022]
- Sven Kili on reconvening with the ISCT - The Medicine Maker - September 14th, 2022 [September 14th, 2022]